Nasus Pharma NSRX
NYSE NSRX
$3.69 +0.09 (+2.36%)
As of: Sep 30, 2026 · 9:52 AM EDT

Nasus Pharma (NSRX) Enterprise Value (2025 - 2026)

Updated

Nasus Pharma (NSRX) posted Enterprise Value of $19.74 million for Q2 2026.

Analysis

Nasus Pharma (NSRX) Enterprise Value (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Nasus Pharma was $14.91 million; for FY2025, it was $78.2 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Nasus Pharma 32.00 Mn 32.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.74 Mn
Dec 31, 2025 78.20 Mn
API Access

Nasus Pharma Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=NSRX&period=max&api_key=YOUR_API_KEY